SGM Alliance

Our Leadership

By promoting awareness, challenging biases, and driving change, we will bridge the gap between marginalized communities and healthcare systems, ensuring that SGM individuals receive effective, equitable, and compassionate care.

Founders & Board of Directors

Garo Kiledjian

Founder, Board President, CEO
Show Bio

Craig Davenport

Board Director
Show Bio

Kemi Williams

Board Director
Show Bio

Michael Wohlfeiler,
JD, MD, AAHIVS

Board Director
AIDS Healthcare Foundation
Show Bio

Advisory Board

Dr. Lauren B. Beach,
JD, PhD

Assistant Professor, Department of Medical Social Sciences, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine
Show Bio

Randy Davis

National Ambassador with the Canadian Foundation for AIDS Research (CANFAR), Board Member of the Ontario AIDS Network
Show Bio

Jacky Goh

Chief Development Officer at
the National LGBTQ Task Force



Show Bio

Terttu Haring, MD


Clinical Operations Executive

Show Bio

Charles Kamen, MPH, PhD

Associate Professor of Surgery, Psychiatry, and Public Health at the University of Rochester Medical Center
Show Bio

Lorena Kuri, MSMHC

Global PBRG Lead OLA (Organization for Latino Achievement),
Bristol Myers Squibb (BMS)
Show Bio

Kelly McKee

Head of Innovative Recruitment at Evinova, AstraZeneca’s digital healthcare company
Show Bio

Lisa Moneymaker

Head of Strategic Customer Engagement | Medidata Solutions
Show Bio

Kunal Patel, MD, BAO, Bch,
BA, MRCS, DTM&H, PhD


International Health physician and Medical Director at iheed

Show Bio

NFN Scout, MA PhD

Executive Director of the
National LGBT Cancer Network
Show Bio

Dr. Ben Young,
MD, PhD, FIDSA

Independent consultant to HIV medicine and street medicine programs. Board member- Wellness Equity Alliance; Center for Public Health and Human Rights, Johns Hopkins University
Show Bio

Garo Kiledjian

Garo Kiledjian is the Founder and Executive Director of SGM Alliance. He is passionate about DEI and offers a unique perspective on how the intersectionality of race and ethnicity overlap with gender and sexuality. Garo serves on the Advisory Board for Arab Board for Clinical Research, is on the Membership Planning Committee for Society for Clinical Research Sites (SCRS), and is on the GALA Executive Committee for the National LGBTQ Task Force, which focuses on legislative and policy changes at the grassroots level in Washington, DC. Garo earned his Bachelor’s from UCLA and studied Leadership and Global Strategy at Woodbury’s Graduate School of Business.

Craig Davenport

Craig is a recent retiree of Eli Lilly and Company where he worked for 34 years in research and development. In all roles at Lilly, Craig championed diversity and equity in clinical research, none more so than his final role as Vice President of Investigator Engagement where he brought the company to be a flagship partner of SGM Alliance. His prior leadership roles at Lilly included working in China for four years as Senior Director China Clinical Development and five years in Japan as Managing Executive Officer & Director of Drug Development for Eli Lilly Japan K.K. Other roles included Chief Operations Officer on the Cialis™ Product Team, which set new standards for innovation in clinical research.

At Lilly, he was twice recognized with Lilly Research Laboratories President’s Award, the Excellence in Alliance Practice Award, and was one of twelve employees selected to serve on the first Lilly President’s Council.

Craig is a graduate of Butler University College of Pharmacy where he continues to be involved in the advancement of health care professional care education, serving two terms on the College of Pharmacy Board of Visitors. Craig was voted Butler’s Outstanding Student in 1990 and later received the Joseph Irwin Sweeney Young Alumni Award. He was later selected to be among the Top 50 Alumni Under 50.

While he now works as a consultant to pharma, focusing on late-stage clinical research innovation, his primary focus is on developing organizations that advance representation of sexual orientation and gender identity minorities. Craig has recently been an invited speaker on the topic of diversity and inclusion in clinical research at SCRS, Scope, and Partners.

He is delighted to join SGM Alliance as a Board Member. The mission of SGM Alliance is one of both passion and purpose for Craig. Never has the imperative of inclusiveness in clinical research been more pressing, and never has science and technology been more aligned to reveal the truths we seek in the development of new medicine.

Kemi Williams

Dr. Williams is a visionary clinical research and health equity leader with 25 years of experience transforming global clinical trials and advancing equitable access to medical innovations. She has driven strategic partnerships, designed and executed trials across diverse therapeutic areas, and built clinical site networks spanning developed and emerging markets.

Most recently at AstraZeneca, Dr. Williams pioneered patient-centered trial representation strategies and health equity frameworks that expanded clinical trial access worldwide. She shaped and launched the company’s external partnership strategy on inclusive research, leading cross-functional teams across Biopharma, Oncology, and Rare Diseases to establish best practices in HCP and health systems engagement. Her leadership fostered research ecosystems supporting equity-based discovery, development, and delivery of innovative therapies, while spearheading collaborations in genomic research and capacity building with leading academic institutions.

Dr. Williams holds a BSc in Computer Science, an MBA, and a PhD in Health Sciences. Her work is fueled by a bold vision: to transform global trial representation and scale equitable health access—not merely to achieve regulatory milestones, but to create lasting health system impact and ensure life-changing medical innovations reach every patient who needs them.

Michael Wohlfeiler

Dr. Wohlfeiler received his medical degree from Rush Medical College in Chicago and then completed his residency in Internal Medicine at Jackson Memorial Hospital/University of Miami. He has specialized in HIV Primary Care Medicine since beginning private practice in 1990. In addition to his private practice, in the 1990’s Dr. Wohlfeiler served as the Medical Director of an AIDS hospice program. He became boarded in Hospice and Palliative Medicine and wrote some of the first hospice guidelines specifically for AIDS patients. The National Hospice Organization (NHO) asked Dr. Wohlfeiler to serve on the its Medical Guidelines Task Force where he wrote the NHO’s hospice guidelines for terminally ill patients with AIDS. From 2000 to 2010, Dr. Wohlfeiler served as the Medical Director for Special Immunology Services (SIS) at Mercy Hospital in Miami. SIS was the largest provider of Ryan White medical and case management services for HIV patients in Dade County. He joined AIDS Healthcare Foundation (AHF) in September 2011 when he and his medical partner agreed to have AHF acquire their private practice. In August 2012, he became Regional Medical Director of AHF’s Southern Bureau and in August 2013 he was asked to become AHF’s Chief Medical Officer.


Dr. Wohlfeiler has been extensively involved in HIV clinical research for 30 years and has served as Principal Investigator in over 100 clinical trials. He has authored book chapters and articles about HIV/AIDS and has been a named author on multiple research papers published in peer-reviewed scientific journals. He has spoken extensively on the topic of HIV/AIDS both in the US and abroad. He is considered a Key Opinion Leader in the field of HIV medicine and has been awarded a multitude of awards and accolades over the past three decades. His peers have selected him as one The Best Doctors in America yearly since 1997 and he was selected by the International Association of Internists as one of “The Leading Physicians in the World.” He received a Red Ribbon Hero Award from the Communities Advocating Emergency AIDS Relief (CAEAR) Coalition and was named one of Miami’s “Twelve Good Men” for 2002.


Prior to attending medical school, Dr. Wohlfeiler attended law school at the University of Arizona. While in law school, Dr. Wohlfeiler was awarded a scholarship to work as a staff assistant with a subcommittee of the United States Senate Judiciary Committee in Washington, DC. After receiving his Juris Doctor (JD) and passing the bar exam, he spent 3 unhappy years working as an attorney. He is much happier being a doctor.

Lauren B. Beach

Lauren B. Beach, JD, PhD, is an Assistant Professor within the Department of Medical Social Sciences and Department of Preventive Medicine in the Feinberg School of Medicine at Northwestern University. They are the director of the ReACH Lab and ADVOCATE Program within Northwestern’s Institute for Sexual and Gender Minority Health and Wellbeing (ISGMH).

Dr. Beach investigates the epidemiology of chronic physical health conditions over the life course among diverse SGM populations and people with HIV. They also study how multilevel health and identity related stigmas affect chronic condition management and health outcomes of minoritized populations.

Along with Sumanas Jordan MD, PhD, they lead the Advancing Opportunities in Clinical and Translational Equity in SGM Health (ADVOCATE SGM Health) Program, which focuses on advocating for good quality care and research-practice-policy improvements in community and public health.

Randy Davis

HIV Activist/Advocate and U=U Champion
The Accidental HIV Activist

Randy Davis is a Canadian HIV advocate, speaker, and writer who has emerged as one of the leading voices promoting U=U (Undetectable = Untransmittable) and challenging stigma in Canada and globally. Diagnosed with HIV in 2015, Randy transformed a personal journey into a platform for public education, advocacy, and policy engagement.

He is the creator of the I Can Give U campaign, an international initiative that humanizes people living with HIV and champions accurate messaging about U=U. Randy also founded InclusHIV Consulting, where he advises organizations, healthcare providers, and advocates on how to build more inclusive and stigma-free practices.

Randy is a National Ambassador with the Canadian Foundation for AIDS Research (CANFAR), sits on the Canadian Coalition to Reform HIV Criminalization, a board member of the Ontario AIDS Network, and a mentor in the International AIDS Society Mentorship Programme. He advocates for a healthcare landscape where people living with HIV and those on PrEP are fully included, respected, and empowered.

A frequent speaker at national and international conferences, Randy was recently awarded the King Charles III Coronation Medal for his contributions to the HIV movement.

You can find his writing and advocacy work at The Accidental HIV Activist on Substack and across social media.

Jacky Goh

Jacqueline “Jacky” Goh serves as the Chief Development Officer for the National LGBTQ Task Force. In this role, Jacky leads the Task Force’s fund development efforts and is responsible for strengthening the infrastructure needed to support and grow the organization’s budget through foundation, corporate, and individual donors, as well as other vital revenue streams.


As a queer Korean woman, Jacky has long understood the importance of allyship and collective liberation. She recognizes the ways that she has benefitted from others who have fought to defend and protect her existence, and she has dedicated her career to paying it forward. In her previous role as Senior Director of Development for the Center for Employment Opportunities, she raised funds to support formerly incarcerated individuals in their reentry into the workforce. She was the Director of Strategic Growth at Define American, a culture change organization that uses the power of narrative to humanize conversations about immigrants. She has also raised funds to advance economic mobility, housing security, and health equity with her work at Restaurant Opportunities Center United, Esperanza Community Housing Corporation, and the Center for Youth Wellness.


Jacky has extensive experience with Board and donor engagement and strategic planning. She holds a Bachelors in Sociology and a Masters in Clinical Psychology with specializations in LGBT Affirmative Psychology and Applied Community Psychology from Antioch University.


Jacky lives in Los Angeles. She is an avid crossworder and grateful companion to two furry felines, Dummy (who is actually very smart) and Alby (who enjoys saying hello on zoom calls).

Terttu Haring

Terttu Haring, MD, is a Clinical Operations Executive with a strong focus on fostering collaboration among investigators, sites, and patients. In the past years, Dr. Haring has led efforts to optimize engagement with clinical sites worldwide, delivering exceptional operational results for each project while ensuring a positive experience for sponsors, sites, and patients alike.

With over 25 years of experience in the clinical development ecosystem, Dr. Haring brings a comprehensive perspective, having worked across research sites, large pharmaceutical companies, and CROs. Her diverse roles have included serving as an investigator and research director, managing local and regional clinical operations teams across the Netherlands, Europe, and Africa, leading global trial operations and data management initiatives, and driving digital innovations in clinical operations.

As a member of the SGM Alliance Advisory Board, Dr. Haring provides leadership support for scientific programming and is committed to expanding the Alliance’s global presence and representation.

Dr. Haring earned her medical degree from Maastricht University in the Netherlands. She resides in Amsterdam on a houseboat with her wife and their youngest child, the third of their three children.

Charles Kamen

Charles Kamen, PhD, MPH, is an Associate Professor in the Department of Surgery and Psychiatry in the Division of Cancer Control at the University of Rochester. He also serves as Assistant Director for Community Outreach and Engagement at the Wilmot Cancer Institute and Chair of Health Equity Research for the University of Rochester Cancer Center NCI Community Oncology Research Program Research Base.  He is a clinical psychologist by training, and his program of research focuses on cancer-related health disparities affecting sexual and gender minority (or LGBTQ+) and other minoritized cancer survivors.  He has over 100 peer reviewed publications. He has also contributed to the development of a range of behavioral interventions with the goal of improving the health and well-being of cancer patients, survivors, and their caregivers, and has worked with national and international organizations around the collection of sexual orientation and gender identity data in oncology.

Lorena Kuri

Lorena Kuri, MSMHC, is recognized for her leadership in advancing diversity in clinical trials at BMS. With extensive experience in the pharmaceutical industry, Lorena is dedicated to promoting health equity. Lorena earned a Bachelors in business degree from Tecnológico de Monterrey and a Masters in Strategic Management and Human Capital from Universidad Anáhuac. She also earned a Certificate in Diversity and Inclusion from Cornell University. Lorena is an active member of the Red Shoe Movement, Women of Color in Pharma (WOCIP), and volunteers for her hometown New Providence Diversity Committee.

Kelly McKee

Kelly McKee is the Head of Innovative Recruitment at Evinova, AstraZeneca’s digital healthcare company where she is responsible for leading the department to develop and deploy digital and innovative patient recruitment strategies and tactics. Kelly is a proven clinical trial leader and trailblazer in operationalizing global patient-focused solutions to improve access, awareness, and inclusion of patients in clinical trials. Prior to Evinova, she spent over 20 years in clinical operations, digital technology, and patient recruitment at top-tier companies, including Sanofi, Merck, Eli Lilly and Co., Medidata, and Vertex Pharmaceuticals. Kelly has been named LifeSci Voice’s Top Industry Leaders (2022), PharmaVoice 100 Most Inspiring Leaders (2020), Centerwatch Top Innovators (2018), and PharmaTimes’ Clinical Researcher of the Year, Clinical Research Team (2012). Kelly lives in Boston with her two sons and three French bulldogs and loves to travel, cook, and write haiku.

Lisa Moneymaker

Lisa Moneymaker is a seasoned leader in the intersection of technology and clinical research, with nearly 25 years of experiences across pharma, biotech, and medical devices. Her roles include leadership of product, engineering, AI research, and customer engagement organizations within both sponsor and product technology companies – supporting the industry’s ever-evolving need for innovative technology to improve clinical development and patient outcomes. Lisa serves as the vice chair of ACRO, and is on the advisory board for the SGM Alliance.

Kunal Patel

Dr. Kunal Patel is an International Health physician and Medical Director at iheed. He is an academic and global health specialist whose work focuses on the themes of global health and the interface between technology, patients, health education and training. Dr. Patel has worked extensively within the international development sector, forming partnerships and developing research, which has been instrumental for primary care system strengthening, improving health outcomes and improved advocacy for the use of public health approaches for clinical research using technology and in advocating for the greater health education globally. He is the Programme Director for the Masters in Public Health at the University of Warwick/iheed and his recent clinical work has focused heavily on supporting the humanitarian response to the conflict in the Middle East and NGO response work. Recent publications have included the world’s leading review on compassion in AI-driven healthcare and narrative reviews on topics such as interprofessional collaboration and learning in diabetes care.

Scout

Scout is the Executive Director of the National LGBT Cancer Network and the principal investigator of both the CDC-funded LGBTQI+ tobacco-related cancer disparity network and Out: The National Cancer Survey. They spend much of their time providing technical assistance for tobacco and cancer focusing agencies expanding their reach and engagement with LGBTQ+ populations. Scout has a long history in health policy analysis and a particular interest in expanding LGBTQI+ surveillance and research. They have faculty appointments at both Brown University and Boston Universities’ Schools of Public Health. They are a member of FDA’s Tobacco Products Scientific Advisory Committee, a longtime member of the NIH Council of Councils, on the Advisory Panel for NIH’s All of Us initiative, and the former Co-Chair of the NIH Sexual and Gender Minority Research Office Work Group. Their work has won them recognition from the U.S. House of Representatives, two state governments, and many city governments. Scout is an openly nonbinary and trans father of three, a vegetarian, an avid hiker and climber.

Ben Young

Dr. Young is currently an Independent consultant to HIV medicine and street medicine programs while also serving as a Board member of the Wellness Equity Alliance at the Center for Public Health and Human Rights, Johns Hopkins University.

His previous role was at ViiV Healthcare as the Senior Global Medical Director. There he was the Co-Chair of the Clinical Trials Diversity Task Force and his responsibilities included supporting the launch of HIV medicines around the world.

Dr. Young’s experiences as Senior Vice President and Chief Medical Officer of the International Association of Providers of AIDS Care (IAPAC), Adjunct Professor at the Josef Korbel School of International Studies at the University of Denver, expert principal on HIV criminalization and consensus statement on the science of HIV in the context of criminal law, and physician providing care for people living with HIV outline his extensive expertise, education, and support for people living with or affected by HIV.

Dr. Young also co-founded and was Medical Director of Rocky Mountain CARES (now ViventHealth) and has extensive digital communications background: serving as a contributing subject matter expert to the HIV websites TheBody.com and Medscape.com, he authored more than 50,000 online articles ranging from “Ask the Doctor” to scientific conference summaries.

Having authored more than 100 peer-reviewed scientific articles and book chapters relating to HIV and its treatment, Dr. Young shared his HIV expertise through worldwide education programs where he has trained healthcare professionals and community groups in over 50 countries.